Belotecan-d7 Hydrochloride (>90%)
CAS: 1346598-22-8
Ref. TR-B131302
| 1mg | 253.00 € | ||
| 5mg | 1,035.00 € | ||
| 10mg | 1,663.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Product Information
Name:
Belotecan-d7 Hydrochloride (>90%)
Controlled Product
Synonyms:
- (4S)-4-Ethyl-4-hydroxy-11-[2-[(1-methylethyl-d7)amino]ethyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Hydrochloride
- CKD 602-d7
Description:
Applications Labelled Belotecan (B131300). A novel camptothecin-derivative anti-tumor agent. CKD-602-related toxicities induced by IV infusion administration have not yet been evaluated, although the drug is more widely used in clinical settings.
References Hertzberg, R., et al.: J. Med. Chem., 32, 715 (1989), Hashimoto, H., et al.: Clin. Cancer Res., 1, 369 (1995), Dahut, W., et al.: J. Clin. Oncol., 14, 1236 (1996),
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
477.0
Formula:
C25H21D7ClN3O4
Purity:
>90%
Color/Form:
Neat
InChI:
InChI=1S/C25H27N3O4.ClH/c1-4-25(31)19-11-21-22-17(12-28(21)23(29)18(19)13-32-24(25)30)15(9-10-26-14(2)3)16-7-5-6-8-20(16)27-22;/h5-8,11,14,26,31H,4,9-10,12-13H2,1-3H3;1H/t25-;/m0./s1/i2D3,3D3,14D;
InChI key:
InChIKey=SJKBXKKZBKCHET-RJGVUDMNSA-N
SMILES:
Cl.[2H]C([2H])([2H])C([2H])(NCCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC)C([2H])([2H])[2H]
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-B131302 Belotecan-d7 Hydrochloride (>90%)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
